Aldeyra Therapeutics, Inc. (ALDX)
1.81
-0.02
(-1.09%)
USD |
NASDAQ |
Mar 20, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Research and Development Expense (Quarterly) : 4.304M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Rhythm Pharmaceuticals, Inc. | 42.03M |
| Pfizer Inc. | 3.133B |
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| MediciNova, Inc. | 1.539M |
| Altimmune, Inc. | 18.38M |